ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,095.20
      -1.02%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.67
      -0.13%
      Bitcoin
      65,912.17
      -0.02%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Bellevue Life Sciences Acquisition Corporation (BLAC)

      7. Bellevue Life Sciences Acquisition Corporation (BLAC) Financials

      Bellevue Life Sciences Acquisition Corporation

      Bellevue Life Sciences Acquisition Corporation (BLAC)

      NASDAQ
      10.80
      -0.04
      (-0.37%)
      Closed July 24 4:00PM
      Delayed by 15 minutes
      10.80
      0.00
      (0.00%)
      After Hours: 5:26PM
      Delayed by 15 minutes

      Bellevue Life Sciences Acquisition Corporation Financial Summary

      The current BLAC market cap is 60.73M. The company's latest EPS is USD 0.0718 and P/E is 150.42.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)
      Total Revenue 00000
      Operating Income -278k-280k-411k-862k-451k
      Net Income 110k302k78k-86k-60k
      Year End December 30 2023 20222023
      USD ($)USD ($)
      Total Revenue 00
      Operating Income -35k-1.83M
      Net Income -35k404k

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)
      Total Assets 71.06M71.49M72.14M36.63M37.27M
      Total Liabilities 2.47M2.61M3.18M4.11M4.82M
      Total Equity -1.83M-2.1M-2.46M-3.91M-4.31M
      Year End December 30 2023 20222023
      USD ($)USD ($)
      Total Assets 1.23M36.63M
      Total Liabilities 1.26M4.11M
      Total Equity -37k-3.91M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)
      Operating -49k-396k-539k-819k-42k
      Investing -70.21M-70.21M-70.21M-33.83M-120k
      Financing 70.48M70.48M70.68M34.54M150k
      Year End December 30 2023 20222023
      USD ($)USD ($)
      Operating -4k-819k
      Investing N/A -33.83M
      Financing 124k34.54M

      Stats and Ratios

      Market Cap 60.73M
      Price to Earnings Ratio 150.42
      Price to Sales Ratio 0
      Price to Cash Ratio 4k
      Price to Book Ratio 1.87
      Dividend Yield -

      Share Statistics

      Shares Outstanding 5.62M
      Average Volume (1 week) 45
      Average Volume (1 Month) 1.43k
      52 Week Change 4.35%
      52 Week High 11.60
      52 Week Low 10.28
      Spread (Intraday) 6.63 (38.28%)

      Company Info

      Company Name Bellevue Life Sciences Acquisition Corporation
      Address 8 the green, ste r
      dover, delaware 19901
      Website https://
      Industry blank checks (6770)